|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 231/12 | |
| A61K 31/415 | |||
| A61P 7/00 |
| (11) | Patento numeris | 2018372 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07794969.1 |
| Europos patento paraiškos padavimo data | 2007-05-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-01-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-05-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/011810 |
| Data | 2007-05-17 |
| (87) | Numeris | WO 2007/136689 |
| Data | 2007-11-29 |
| (30) | Numeris | Data | Šalis |
| 801789 P | 2006-05-18 | US | |
| 921318 P | 2007-04-02 | US |
| (72) |
GHARBAOUI, Tawfik, US
SENGUPTA, Dipanjan, US
KRISHNAN, Ashwin M., US
SHAH, Nainesh, US
MACIAS, Mark, US
HART, Ryan M., US
LALLY, Edward A., US
DUFFIELD, Jonathan J, US
|
| (73) |
Arena Pharmaceuticals, Inc.,
6154 Nancy Ridge Drive, San Diego, CA 92121,
US
|
| (54) | CRYSTALLINE FORMS AND PROCESSES FOR THE PREPARATION OF PHENYL-PYRAZOLES USEFUL AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR |
| CRYSTALLINE FORMS AND PROCESSES FOR THE PREPARATION OF PHENYL-PYRAZOLES USEFUL AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR |